Recent advances in subtyping of biliary tract carcinoma
Journal Title: Journal of Surgery : Concepts & Practice - Year 2024, Vol 29, Issue 2
Abstract
Biliary tract carcinoma exhibits high heterogeneity at the genomic, epigenetic, and molecular expression levels. The patients even with the same pathological morphology and clinical stage of biliary tract malignant tumors have substantial differences in the treatment response and prognosis. Traditional pathological histology and clinical classifications are no longer sufficient to meet the demands of the precision medicine era. Molecular subtyping has the potential to provide more personalized cancer treatment strategies. It not only helps to reveal the mechanisms of tumor development and accurately predict disease prognosis, but also plays a crucial role in guiding the development of novel targeted drugs and implementing targeted therapies for specific tumors. With the ongoing development of precision medicine, the role of molecular subtyping in cancer diagnosis, treatment option, and prognosis assessment is increasingly prominent. This paper systematically reviewed the recent progress in the molecular subtyping of biliary tract malignant tumors based on domestic and international clinical and basic research.
Authors and Affiliations
Zhiwen LIN, Hongzhi LIU, Yongyi ZENG
Application of ERCP in diagnosis and treatment of biliary complications during perioperative period of primary liver cancer
[Objective:] To review the experience of using endoscopic retrograde cholangio-pancreatography (ERCP) in the clinical diagnosis and treatment of biliary complications during perioperative period of primary liver cancer a...
Challenges and opportunities in the diagnosis and treatment of thyroid carcinoma in children and young adolescents
Thyroid carcinoma in children and young adolescent is a special type of thyroid carcinoma, which has received more and more attention. In recent years, confusion and difficulties continue to emerge in understanding the d...
Complications of implanted subcutaneous port for intraperitoneal chemotherapy in gastric cancer patients with peritoneal metastasis and analysis of risk factors of complications
[Objective] To analyze the port complications and risk factors associated with the port complications in gastric cancer patients with peritoneal metastasis. [Methods] The medical records of 323 patients with subcutaneous...
Analysis of tumor recurrence factors of the patients with intermediate risk papillary thyroid carcinoma after radioactive iodine treatment
[Objective] To analyze the recurrence factors of the patients with intermediate risk papillary thyroid carcinoma (PTC) after radioactive iodine treatment (RAIT). [Methods] A total of 254 intermediate risk PTC patient...
<![CDATA[Research progress in organ preservation strategies for early rectal cancer]]>
<![CDATA[This review explored recent advancements in organ preservation strategies for early rectal cancer. Although total mesorectal excision (TME) remains the standard treatment, there is a growing interest in organ pr...